Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
227.87
-8.39 (-3.55%)
Dec 5, 2024, 4:00 PM EST - Market closed

Company Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands.

The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products.

This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings.

The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development.

The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.

Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Danaher Corporation
Danaher logo
Country United States
Founded 1969
Industry Diagnostics & Research
Sector Healthcare
Employees 63,000
CEO Rainer Blair

Contact Details

Address:
2200 Pennsylvania Avenue, North West, Suite 800 West
Washington, District of Columbia 20037-1701
United States
Phone 202 828 0850
Website danaher.com

Stock Details

Ticker Symbol DHR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000313616
CUSIP Number 235851102
ISIN Number US2358511028
Employer ID 59-1995548
SIC Code 3823

Key Executives

Name Position
Rainer M. Blair President, Chief Executive Officer and Director
Steven M. Rales Co-Founder and Chairman
Mitchell P. Rales Co-Founder and Director
Matthew R. McGrew Chief Financial Officer and Executive Vice President
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. Senior Vice President and Chief Science Officer
Georgeann F. Couchara Senior Vice President of Human Resources
Christopher M. Bouda Vice President and Chief Accounting Officer
John Bedford Vice President of Investor Relations
Brian W. Ellis J.D. Senior Vice President, General Counsel and Chief Compliance Officer
Daniel A. Raskas J.D. Senior Vice President of Corporate Development

Latest SEC Filings

Date Type Title
Nov 26, 2024 144 Filing
Nov 25, 2024 144 Filing
Nov 5, 2024 144 Filing
Oct 23, 2024 144 Filing
Oct 22, 2024 8-K Current Report
Oct 22, 2024 10-Q Quarterly Report
Aug 26, 2024 144 Filing
Aug 13, 2024 144 Filing
Aug 1, 2024 144 Filing
Aug 1, 2024 144 Filing